SLACOM - Sociedad Latinoamericana y del Caribe de Oncología Médica
   • Grants & Awards
   • Campaigns
   • Various Announcements
Grants & Awards

18.03.2013 | ASCO Special Awards 2013 - Leading Investigators Honored for Outstanding Contributions to the Field of Oncology
March 15, 2013 Alexandria, VA

Seventeen leaders in oncology are to be recognized for their dedication to improving the lives of people living with cancer. Among the awardees are the director of the Office of Hematology and Oncology Products in the Center for Drug Evaluation and Research of the U.S. Food and Drug Administration and a scientist belonging to the group that performed the first genome-wide association study of BRCA2 breast cancer.

Each year through its Special Awards Program, ASCO recognizes researchers, patient advocates, and leaders of the global oncology community who, through their work, have made significant contributions to enhancing cancer care. These recipients of ASCO’s highest, most prestigious awards collectively represent significant strides in cancer treatment and leadership in the oncology community.

“The recipients of this year’s awards are the past, present and future of our field,” said Michael P. Link, MD, Immediate Past President of ASCO and Chair of the Special Awards Selection Committee. “They have contributed tremendously to the body of work that is improving the treatment and care of people with cancer. It is our honor to bestow these awards upon them.”

SLACOM’s Founding President, Dr. Eduardo Cazap is one of the seventeen.

For more information go to:


Related Links
Copyright © 2008 SLACOM. All rights reserved.
Developed by: Unlimited ideas